Russia's largest manufacturer of socially significant drugs. The company specializes in the development and manufacture of TB, anti-cancer, anti-retroviral, anti-diabetic drugs as well as antibiotics. Pharmasyntez is a leader in the production of antiretroviral and TB medications. The company manufactures practically the entire range of TB drugs registered in Russia, including new generation TB medications. The company's product portfolio includes 165 medications. Pharmasyntez was a leading supplier to hospitals in Russia among Russian companies in 2016. The company has seen stunning growth in the past 3 years, consistently rating as the fastest growing pharmaceutical company in Russia. By taking an active part in the implementation of state programs, Pharmasyntez has earned a reputation as a reliable partner always willing to support the development strategy of the Russian government and achieve the best results in the Pharma-2020 program.
JSC “R-Pharm” is a Russian high-technology pharm company. Its activities embrace areas related to development, research, production and bringing to market of a wide range of innovative medications primarily for hospital and specialized care. Today more than 3500 highly skilled professionals work in the company. In Russia there are over 60 business units and representative offices of the company. R-Pharm operates on the territory of CIS countries, USA, Germany, Japan, UAE, Turkey and India. The corporate structure includes pharm manufacturing facilities located in Yaroslavl, Kostroma region, Novosibirsk and Germany. A new advanced research and production complex on development of API’s in Rostov, biotech drug manufacturing plant in Turkey and the first pharm complex that comprises manufacturing, laboratory and logistics units in Azerbaijan are all under construction.
CV PROTEK is a leading national distributor of pharmaceutical products in Russia.
CV PROTEK has a logistic and warehouse system that complies with world standards and is capable of bringing products maximally close to the end consumer. The company’s large-scale regional chain is comprised of 42 branches and covers the entire territory of the Russian Federation.
Established in 1990, CV Protek has for the past 25 years set the vector of development of the entire distribution segment, demonstrating continuous development and offering innovative business solutions to its partners and clients.
CV PROTEK is part of PROTEK Group of Companies.
Proxima Research LLC is part of an international group of companies, which includes key solution-vendors for the life-science industry in CIS countries, covering the complete scope of pharmaceutical companies’ needs in IT-solutions, data for decision-making and product promotion for the last 15 years. Proxima Research LLC provides expert solutions in the area of CRM/ETMS integration and support, HCP/HCO database management, multichannel marketing, BI-solution’s implementation, IT-development, market data, marketing research and consulting.
Аналитическая компания AlphaRM предоставляет полный спектр аналитических и маркетинговых услуг в сфере фармации.
Аудит розничных продаж ЛС (sell out)
Аудит закупок ЛС аптечными учреждениями (sell in) Геомаркетинг аптечных учреждений Аудит отгрузок ЛС в ЛПУ Аудит федерального сегмента льготного обеспечения ЛС Аудит регионального сегмента льготного обеспечения ЛС Паспортизация аптечного сегмента Мониторинг государственных закупок Аудит целевого сегмента поставок ЛС
Established in 2000, Santens Service group is one of the largest pharmaceutical operators in Russia. The group specializes in providing customs and logistics services for pharmaceutical products on the territory of the Russian Federation.
The group’s customers comprise both national and international manufacturers and distributors of pharmaceuticals and include Pfizer, Teva, Bayer, Novartis group, AstraZeneca, Valeant, Actavis, Servier, Queisser Pharma, Eli Lilly, Boiron, Johnson&Johnson, Boehringer Ingelheim, Katren, Doctor Reddy’s Laboratories, Biotec, UCB Pharma, Ranbaxy, Boehringer Ingelheim, Abbott Laboratories, Orion Pharma, MSD Pharmaceuticals and Grindeks.
The company’s goal is to facilitate patients’ access to the best medicines and reduce the cost of treatment by introducing a new supply chain business model from manufacturer to patient.
We achieve our goal by further developing key competences and introducing new ones, ranging from service distribution and specialized logistics solutions to the development of medicine reimbursement technologies.
In 2017 the total storage capacity of the group amounted to 150,000 pallets. The total import turnover of Santens Service group’s clients exceeded $4.5 billion over the said period.
Inpharmatis has more than 20 years of experience providing in-depth and full scale services in regulatory affairs and GxP. Today Inpharmatis is the sole provider of full scale regulatory and pharmacovigilance services with full EU and CIS country coverage with the highest quality standards. We are the only ones in the CIS offering full digitalisation of pharmaceutical companies by introduction of DMS, eCTD, and many other innovative and leading electronic solutions for more efficient management of pharmaceutical business.
EUROTHERM is a global manufacturer of instrumentation, systems and services designed for the efficient operation of industrial processes.
We can help with regulatory requirements, improving the performance of your processes and provide you with tailored agreements to give you peace of mind for your business.
For more than 65 years Baker McKenzie has been effectively providing global advice in the pharmaceutical sector, and for over 25 of those years providing such advice here in the CIS. The size and global reach of our Firm, with its 77 offices in 47 countries, guarantee that know-how is shared among jurisdictions and allow resources from our international network to supplement local office needs. Having assisted in the foundation of the Association of International Pharmaceutical Manufacturers and the International Medical Devices Manufacturers Association, we advise clients on the full spectrum of legal concerns in the CIS, including customs and trade regulation, as well as WTO and EurAsEC-consistent policy. (www.bakermckenzie.com)
The marketing agency RX Code is one of the leaders in the Russian market of pharmaceutical products and medical equipment promotion.
The company is an expert in the provision of services for personnel outsourcing, remote communication with doctors and pharmacies, organization of training courses and special social projects, as well as in creative solutions for all types of media.
The communication group «Aaron Lloyd» is a media agency, working in the pharmaceutical market since 1999.
We have a lot of expert employees, including a Medical director, who provide additional support to our clients in relation to marketing.
We are involved in strategic and tactical media-planning, econometric modelling and implement unusual projects and 360° campaigns. We also provide educational programs for our Clients.
«Aaron Lloyd» agency is the only subscriber for industrial data from QuintilesIMS and Alpharm.
From 2014 the agency has been a strategic partner of Dentsu Aegis Network group in Russia.
From 2016 a special medical program «Agents 003» is broadcast on TNT channel with involvement of the Agency «Aaron Lloyd».
STEM is the global benchmarking company that partners with 29 of the top 30 pharmaceutical companies to further accelerate performance. We work with commercial, field medical, field access and account management teams. Our benchmark database is the biggest in the industry, built on >300,000 in-field observations. We partner with your Brand Team, to identify practical evidence-based recommendations.
The STEM vision is to be in every brand plan, working to highly professional core values.
We are based in seven offices globally, a presence in >40 countries, and experience in all therapy areas.
STEM received the prestigious Queen’s Award for Enterprise, recognising the contribution to international trade, in 2016.
For further information visit our website at www.stemhealthcare.com
Medical-Pharmaceutical Unity (MPU) is a large commercial marketing association of independent pharmacy chains. Being one of the top pharmacy associations, MPU welcomes both small and large pharmacy chains – working with more than 2300 pharmacies and developing our own distribution channel of non-medicinal pharmacy-sold products. MPU treats every partner with respect and care and allows regional and local players to use the benefits of large federal chains.
Any member of our association is free to join either our standard partnership plan or our Loyalty Program. The standard plan allows the partner to receive various marketing bonuses, while the Loyalty Program implies deeper interaction as well as a joint customer attraction program.
MPU’s distinctive features include total transparency of cooperation, fulfillment of obligations to partners, preservation of our partners' independence and absence of any additional burdensome obligations.
Ipsos Healthcare Russia as a part of the Global Ipsos Healthcare specializes on Russian Healthcare market for over past two decades and working with the most of market players and their HQs.
Deep understanding of the Russian healthcare and pharmaceutical market coupled with a wide range of analytical services and modern research tools allows us to keep a leading position in this segment.
Almost 50 employees Ipsos Healthcare (Russia) focusing exclusively on Healthcare research and offering a full range of services in the following areas: Syndicated research, Custom research (AdHoc), Analytics and consultancy and Educational trainings.
Our Syndicated Surveys cover over 15 000 physicians and more than 4 500 pharmacists annually providing our clients with actual and precise data on the Russian pharmaceutical market.
Custom research both for Qualitative and Quantitative parts and also supporting by our Analytics&Consultancy service allows our clients to update regularly market feedback on various segments.
Educational project School of Pharmaceutical Marketing within last 9 years offers a wide range of educational workshop and training programs conducted by leading trainers and market experts.
Established in 1994. The Association comprises 60 international pharmaceutical companies that provide over 80% of the world’s pharmaceutical products and over 60% of medicines imported to the Russian Federation.
To promote economic and legal policies that focus on the development of organized and open pharmaceutical market, improving of medical services quality and expansion of the range of modern medicines for the benefit of Russian people.
The Franco-Russian Chamber of Commerce and Industry (CCI France Russie) is an independent lobbying body that represents and promotes the economic interests of its Franco-Russian member companies. It has been operating in Moscow since 1997, and today it brings together more than 450 companies from 40 sectors of the economy. Its work is focused on 3 key areas: building the business community, lobbying and support for companies.
Since 1994 the Mid-Atlantic - Eurasia Business Council (MAEBC/MARBC) has worked to foster business relations between Eurasia and the U.S. Mid-Atlantic region. The goal of MAEBC/MARBC is to enable companies based in the U.S. Mid-Atlantic region to enhance their positions in Eurasia/Russia and to attract Eurasian/Russian businesses to the U.S. Mid-Atlantic region. A major focus of MAEBC/MARBC's efforts has been the establishment of the Mid-Atlantic region as a leading partner for Eurasian - American technology cooperation. The most prominent of the annual events organized by the MAEBC/MARBC are the Eurasian - American Innovation Technology Weeks (RANIT) and Days of Eurasian - American Innovation Entrepreneurship Cooperation.
During the past decade one of the Mid-Atlantic - Eurasia Business Council's main priorities has been Eurasian-American partnership in biotechnology and life sciences. To achieve this goal, MAEBC/MARBC organizes American and Eurasian participation in the most important international life sciences events.
Remedium group of Companies renders the whole range of services for specialists in the field of medicine and pharmaceutics. For years the principle directions of activity of “Remedium” Group of Companies are publication of particularized periodicals, assignment of electronic databases, arrangement and implementation of measures, rent-a-rep service, organization of advertisement and PR support.
Interfax is the biggest information group in the CIS and the recognized leader in the B2B segment of Russia’s information market.
Interfax is the most frequently cited source for information on Russia and the CIS in the foreign press.
Interfax develops professional information solutions that help companies operate in the financial and commodity markets, enabling them to reach investment decisions, manage risk, organize external communications and fulfill regulatory requirements.